📰 Guy Rigaud News
Guy Rigaud News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Guy Rigaud. Real-time updates on events, politics, business and more.
May 16, 2023
▪Entry into a definitive merger agreement between ERYTECH and PHERECYDES ▪Completion of a contribution in kind of PHERECYDES shares to ERYTECH ... | May 16, 2023
May 16, 2023
Entry into a definitive merger agreement between PHERECYDES and ERYTECH Combination with ERYTECH to be submitted to shareholders' vote on June 23, 2023 Completion of a contribution in
May 15, 2023
ERYTECH Provides Update on the Announced Combination with PHERECYDES Entry into a definitive merger agreement between ERYTECH and PHERECYDESCompletion... | May 15, 2023
May 15, 2023
ERYTECH Provides Update on the Announced Combination with PHERECYDES Entry into a definitive merger agreement between ERYTECH and PHERECYDESCompletion of a contribution in kind of PHERECYDES
February 17, 2023
This capital increase, fully subscribed by Auriga IV Bioseeds, Ouest Ventures III and the pool of shareholders represented by Guy Rigaud, historical shareholders of Pherecydes Pharma, is part of
February 15, 2023
Conference call and webcast in English on February 16, 2023 at 8:30am EST 02:30pm CET and in French on the same day at 12pm EST 6pm CET Strategic combination would build on complementary expertise
September 22, 2022
Regulatory News: Not for release, either directly or indirectly, in the United States, Canada, Australia or Japan. Pherecydes Pharma (FR0011651694 ALPHE) (Paris:ALPHE), a biotechnology company
September 21, 2022
Global Offering aimed at institutional investors, as well as individual investors via the PrimaryBid platform Subscription commitments totaling at least €2.3 million from longstanding shareholders